Excess body weight can increase blood pressure by raising inflammation, affecting insulin resistance, increasing fluid retention, and placing more strain on the cardiovascular system
Wegovy does not directly affect immune function, but significant weight loss and metabolic changes can influence overall health status
Emerging Research and Clinical Evidence While research in this area is still evolving, early studies show promising results: A review of health records for over 220,000 smokers with type 2 diabetes found that those prescribed semaglutide (a GLP-1 receptor agonist) were less likely to have medical encounters related to smoking compared to patients on other anti-diabetes medications
[1] That is the central clinical point
If there are concerns about potential allergic reactions, changes in mental health, or unexpected symptoms, consult a healthcare provider
Before joining Wolters Kluwer, Ms